6th May 2010 17:33
GlaxoSmithKline plc - Result of AGM
GlaxoSmithKline (GSK) announces that at its Annual General Meeting today, all resolutions, including those electing and re-electing Board members, were passed by shareholders.
GlaxoSmithKline Annual General Meeting Poll Results
The following table shows the votes cast for each resolution:
|
Resolution |
Total votes for* |
% |
Total votes against |
% |
Total votes cast |
Votes withheld** |
|
|
1 |
Adoption of Financial Statements |
3,598,418,923 |
98.82 |
43,141,670 |
1.18 |
3,641,560,593 |
5,644,370 |
|
2 |
Approval of the Remuneration Report |
3,541,237,234 |
97.79 |
79,954,611 |
2.21 |
3,621,191,845 |
26,063,218 |
|
3 |
Re - Election of Dr Stephanie Burns |
3,623,167,103 |
99.42 |
21,029,709 |
0.58 |
3,644,196,812 |
2,994,975 |
|
4 |
Re-election of Julian Heslop |
3,614,453,830 |
99.40 |
21,794,823 |
0.60 |
3,636,248,653 |
10,945,821 |
|
5 |
Re-election of Sir Deryck Maughan |
3,610,735,860 |
99.09 |
33,299,858 |
0.91 |
3,644,035,718 |
3,157,277 |
|
6 |
Re-election of Dr Daniel Podolsky |
3,611,533,790 |
99.11 |
32,510,583 |
0.89 |
3,644,044,373 |
3,147,398 |
|
7 |
Re-election of Sir Robert Wilson |
3,610,344,137 |
99.08 |
33,643,265 |
0.92 |
3,643,987,402 |
3,191,304 |
|
8 |
Re-appointment of Auditors |
3,478,245,182 |
96.93 |
110,136,263 |
3.07 |
3,588,381,445 |
58,819,622 |
|
9 |
Remuneration of Auditors |
3,564,492,662 |
98.45 |
56,106,748 |
1.55 |
3,620,599,410 |
26,616,714 |
|
10 |
To authorise the company to make donations to Political Organisations & incur Political Expenditure |
3,542,930,783 |
97.36 |
95,902,968 |
2.64 |
3,638,833,751 |
8,442,409 |
|
11 |
Authority to allot shares |
3,522,619,757 |
96.76 |
118,105,636 |
3.24 |
3,640,725,393 |
6,450,059 |
|
12 |
Disapplication of pre-emption rights*** |
3,605,918,864 |
99.14 |
31,425,913 |
0.86 |
3,637,344,777 |
9,718,766 |
|
13 |
Authority for the Company to purchase its own shares*** |
3,589,455,513 |
98.56 |
52,518,615 |
1.44 |
3,641,974,128 |
5,301,338 |
|
14 |
Exemption from statement of senior statutory auditor's name |
3,624,009,356 |
99.65 |
12,682,719 |
0.35 |
3,636,692,075 |
10,468,603 |
|
15 |
Reduced notice of a general meeting other than an AGM*** |
3,367,402,408 |
92.71 |
264,960,544 |
7.29 |
3,632,362,952 |
14,848,460 |
|
16 |
Adoption of new Articles of Association*** |
3,576,628,823 |
99.44 |
20,021,827 |
0.56 |
3,596,650,650 |
50,514,919 |
Notes:
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority
The following table provides further relevant information:
|
|
GlaxoSmithKline's Tenth AGM (2010)
|
GlaxoSmithKline's Ninth AGM (2009)
|
|
Issued share capital (excluding Treasury Shares) |
5,192,489,588 |
5,188,385,638 |
|
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) |
70.24% |
73.50% |
|
Total shareholder population |
164,450 |
170,054 |
|
Total number of proxies lodged |
11,148 |
10,580 |
|
% of shareholders who lodged proxies |
6.78% |
6.22% |
|
Number of shareholders, corporate representatives and proxies who attended the AGM |
325 |
276 |
S M Bicknell
Company Secretary
6 May 2010
These results will shortly be available on the Company's website www.gsk.com.
Enquiries:
|
GlaxoSmithKline Enquiries: |
|
|
|
UK Media enquiries: |
Philip Thomson |
(020) 8047 5502 |
|
|
Claire Brough |
(020) 8047 5502 |
|
|
Stephen Rea |
(020) 8047 5502 |
|
|
Alexandra Harrison |
(020) 8047 5502 |
|
|
Jo Revill |
(020) 8047 5502 |
|
|
|
|
|
US Media enquiries: |
Nancy Pekarek |
(919) 483 2839 |
|
|
Mary Anne Rhyne |
(919) 483 2839 |
|
|
Kevin Colgan |
(919) 483 2839 |
|
|
Sarah Alspach |
(919) 483 2839 |
|
|
|
|
|
European Analyst/Investor enquiries: |
David Mawdsley |
(020) 8047 5564 |
|
|
Sally Ferguson |
(020) 8047 5543 |
|
|
Gary Davies |
(020) 8047 5503 |
|
|
|
|
|
US Analyst/ Investor enquiries: |
Tom Curry |
(215) 751 5419 |
|
|
Jen Hill Baxter |
(215) 751 7002 |
Related Shares:
Glaxosmithkline